These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 14106543

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. THE EFFECT OF A PHTHALANILIDE DERIVATIVE ON LIPIDE METABOLISM IN L1210 LEUKEMIA CELLS.
    GELLHORN A, WAGNER M, RECHLER M, KOREN Z, BENJAMIN W.
    Cancer Res; 1964 Apr; 24():400-8. PubMed ID: 14147813
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. FLUORINATED PYRIMIDINES. XXI. THE TUMOR-INHIBITORY ACTIVITY OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.
    HEIDELBERGER C, ANDERSON SW.
    Cancer Res; 1964 Dec; 24():1979-85. PubMed ID: 14247510
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. QUANTITATIVE CONCEPTS IN THE CLINICAL STUDY OF DRUGS.
    ZUBROD CG.
    Adv Chemother; 1964 Dec; 12():9-34. PubMed ID: 14198208
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. OSSAMYCIN, A NEW CYTOTOXIC AGENT.
    SCHMITZ H, JUBINSKI SD, HOOPER IR, CROOK KE, PRICE KE, LEIN J.
    J Antibiot (Tokyo); 1965 Mar; 18():82-8. PubMed ID: 14326088
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XVII.
    LEITER J, ABBOTT BJ, SCHEPARTZ SA, WODINSKY I.
    Can Res Suppl; 1964 Feb; ():211-459. PubMed ID: 14119369
    [No Abstract] [Full Text] [Related]

  • 36. SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XVI.
    LEITER J, ABBOTT BJ, BOURKE AR, SCHEPARTZ SA, WODINSKY I.
    Can Res Suppl; 1963 Nov; ():1930-2033. PubMed ID: 14085011
    [No Abstract] [Full Text] [Related]

  • 37. SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XX.
    LEITER J, ABBOTT BJ, MACDONALD MM, SCHEPARTZ SA.
    Cancer Res; 1964 Jul; 24():880-1080. PubMed ID: 14204395
    [No Abstract] [Full Text] [Related]

  • 38. The influence of treatment schedule on the chemotheapy of advanced leukemia L1210 in mice.
    VENDITTI JM, GOLDIN A, KLINE I.
    Cancer Chemother Rep; 1960 Feb; 6():55-7. PubMed ID: 13841660
    [No Abstract] [Full Text] [Related]

  • 39. A SYSTEMATIC INVESTIGATION OF THIOXANTHEN-9-ONES AND ANALOGS AS POTENTIAL ANTITUMOR AGENTS.
    BLANZ EJ, FRENCH FA.
    J Med Chem; 1963 Mar; 6():185-91. PubMed ID: 14188792
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.